Natixis Advisors LLC Acquires 18,699 Shares of Envista Holdings Co. (NYSE:NVST)

Natixis Advisors LLC increased its stake in shares of Envista Holdings Co. (NYSE:NVST) by 21.7% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 104,807 shares of the company’s stock after acquiring an additional 18,699 shares during the quarter. Natixis Advisors LLC’s holdings in Envista were worth $2,071,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. purchased a new position in Envista in the third quarter worth $31,000. GAMMA Investing LLC boosted its holdings in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock worth $35,000 after buying an additional 726 shares during the last quarter. Huntington National Bank grew its position in Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after buying an additional 949 shares during the period. Blue Trust Inc. increased its holdings in Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after buying an additional 804 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its position in Envista by 50.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after acquiring an additional 728 shares during the period.

Envista Trading Up 0.4 %

Shares of NVST stock opened at $21.48 on Monday. The business has a 50-day moving average of $19.48 and a 200 day moving average of $18.17. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. Envista Holdings Co. has a 1-year low of $15.15 and a 1-year high of $25.64. The stock has a market capitalization of $3.70 billion, a PE ratio of -2.76, a P/E/G ratio of 2.98 and a beta of 1.30.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.03. The firm had revenue of $601.00 million during the quarter, compared to analyst estimates of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The business’s quarterly revenue was down 4.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.43 earnings per share. As a group, sell-side analysts anticipate that Envista Holdings Co. will post 0.72 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on NVST. Bank of America reduced their target price on shares of Envista from $22.00 to $19.00 and set a “buy” rating for the company in a research report on Thursday, August 8th. Robert W. Baird raised their target price on Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research report on Thursday, October 31st. Piper Sandler lifted their price objective on Envista from $16.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Finally, Leerink Partners raised shares of Envista from an “underperform” rating to a “market perform” rating and upped their price objective for the company from $16.00 to $23.00 in a report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $20.71.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.